Loading...
UK Trademark — IPO
DCVAX
Application UK00912923231 · Registered
Quick Facts
| Application Number | UK00912923231 |
| Status | Registered |
| Owner | Northwest Biotherapeutics, Inc. |
| Filed | 2014-05-30 |
| Registered | 2014-10-22 |
| Renewal Due | 2034-05-30 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. DCVAX is currently a registered UK trademark, with renewal due on 2034-05-30. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Medical preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators; Derivatives and modulators of immune cells, namely, vaccines, proteins, peptides, enzymes, cytokines, chemokines, antibodies, DNA, RNA, growth factors, cell lysate, extracellular matrix and conditioned media for medical or veterinary use; Vaccines.
Timeline
- Filed: 2014-05-30
- Registered: 2014-10-22
- Renewal due: 2034-05-30
About This Trademark
'DCVAX' is a registered trademark on the UK IPO register, owned by Northwest Biotherapeutics, Inc.. The application (UK00912923231) was filed on 30 May 2014 and registered on 22 October 2014. The registration is set to expire on 30 May 2034.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Mewburn Ellis LLP.
Frequently Asked Questions
Who owns UK trademark UK00912923231 ('DCVAX')?
UK trademark UK00912923231 for the mark 'DCVAX' in Class 5 is recorded on the UK IPO register as owned by Northwest Biotherapeutics, Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00912923231 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00912923231 for the mark 'DCVAX' as registered.
Which goods or services does UK trademark UK00912923231 cover?
UK trademark UK00912923231 for the mark 'DCVAX' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Immune cells, namely cells for medical or veterinary use; Biotechnology preparations for the prevention, management and treatment of cancer, or for the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extent, timing or duration of the immune respons…
When was UK trademark UK00912923231 filed?
UK trademark UK00912923231 for the mark 'DCVAX' was filed at the UK IPO on 30 May 2014 and registered on 22 October 2014.
When does UK trademark UK00912923231 need to be renewed?
UK trademark UK00912923231 for the mark 'DCVAX' is currently recorded as valid until 30 May 2034, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00912923231?
Mewburn Ellis LLP is listed as the attorney / representative of record for UK trademark UK00912923231 for the mark 'DCVAX' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "DCVAX" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| DCVAXSame applicant | 86298423 | 702 | 2014-06-03 |
| DCVAXSame applicant | 76029211 | 800 | 2000-04-19 |
Australia — Australia (IP Australia)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| DCVAXSame applicant | 1627849 | protected | 2014-06-11 |
| DCVAXSame applicant | 1610996 | protected | 2014-03-13 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australia (IP Australia)
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.